Pring Turner Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pring Turner Capital Group's LLY Position: Q2 2026 in Review
Pring Turner Capital Group reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $5.11K and leaving 366 shares worth $436K. The position accounts for 0.25% of the portfolio, ranked #48.
Pring Turner Capital Group first reported a position in LLY in Q4 2013 and has held it in 16 quarters since. The position peaked at $541K in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Pring Turner Capital Group held 366 shares of Eli Lilly worth $436K as of Q2 2026.
- Pring Turner Capital Group sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
- Eli Lilly made up 0.25% of Pring Turner Capital Group's portfolio in Q2 2026, its #48 holding.
- Pring Turner Capital Group first reported a position in Eli Lilly in Q4 2013 and has held it in 16 quarters since.
- Pring Turner Capital Group's Eli Lilly position peaked at $541K in Q2 2024.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Pring Turner Capital Group's 13F filing for Q2 2026, filed 10 Aug 2026.